CLINICAL_TRIALS ClinicalTrials.gov record update

Post-Marketing Surveillance of MabThera Subcutaneous in Patients With Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT03289182
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:37:52.432110+00:00
Published At: 2021-01-11T00:00:00+00:00
Record Updated At: 2021-01-11
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Lymphoma, Non-Hodgkin", "Leukemia, Lymphocytic, Chronic, B-Cell"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2021-01-11"
protocolSection.identificationModule.nctId: "NCT03289182"
protocolSection.identificationModule.officialTitle: "Post-Marketing Surveillance of MabThera Subcutaneous in Patients With Non-Hodgkin\u0027s Lymphoma or Chronic Lymphocytic Leukemia"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: []
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.